These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38283270)

  • 1. Vibration-controlled transient elastography for non-invasive screening of liver fibrosis and steatosis in Turkish patients with psoriasis: A cross-sectional study.
    Aksoy AN; Hanci B; Baskent MF; Umutlu EG; Kumas EN; Emanet SU; Yalcin MO; Duzyol Z; Teker AG; Yilmaz Y
    Hepatol Forum; 2024; 5(1):29-32. PubMed ID: 38283270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students.
    Nastasa R; Stanciu C; Zenovia S; Singeap AM; Cojocariu C; Sfarti C; Girleanu I; Chiriac S; Cuciureanu T; Huiban L; Muzica CM; Trifan A
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients.
    Siddiqui MS; Idowu MO; Stromberg K; Sima A; Lee E; Patel S; Ghaus S; Driscoll C; Sterling RK; John B; Bhati CS
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):367-374. PubMed ID: 32272251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Determinants of Undiagnosed Liver Steatosis and Fibrosis in a Nationally Representative Sample of US Adults.
    Bhattacharyya M; Nickols-Richardson SM; Miller AL; Bhattacharyya R; Frankhauser F; Miller LE
    Cureus; 2023 Oct; 15(10):e46783. PubMed ID: 37954822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.
    Demir M; Deyneli O; Yılmaz Y
    Turk J Gastroenterol; 2019 Mar; 30(3):266-270. PubMed ID: 30411703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter.
    Trifan A; Stratina E; Nastasa R; Rotaru A; Stafie R; Zenovia S; Huiban L; Sfarti C; Cojocariu C; Cuciureanu T; Muzica C; Chiriac S; Girleanu I; Singeap AM; Stanciu C
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Zenovia S; Stanciu C; Sfarti C; Singeap AM; Cojocariu C; Girleanu I; Dimache M; Chiriac S; Muzica CM; Nastasa R; Huiban L; Cuciureanu T; Trifan A
    Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33925569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience.
    Sporea I; Mare R; Popescu A; Nistorescu S; Baldea V; Sirli R; Braha A; Sima A; Timar R; Lupusoru R
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study.
    Wan T; Köhn N; Kröll D; Berzigotti A
    Obes Surg; 2021 Feb; 31(2):702-711. PubMed ID: 32959331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Cao YT; Xiang LL; Qi F; Zhang YJ; Chen Y; Zhou XQ
    EClinicalMedicine; 2022 Sep; 51():101547. PubMed ID: 35844772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatic steatosis and fibrosis in apparently healthy airline pilots: A transient elastography study.
    Minoretti P; Sáez ASS; Martín ÁFG; Riera ML; Serrano MG; Emanuele E
    Hepatol Forum; 2024; 5(1):7-10. PubMed ID: 38283276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
    Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
    Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound liver elastography for the detection of liver fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy: A cross-sectional study.
    Khandpur S; Yadav D; Jangid B; Kumar A; Shalimar ; Devasenathipathy K; Sharma R; Gupta SD; Kumar R; Kalaivani M
    Indian J Dermatol Venereol Leprol; 2020; 86(5):508-514. PubMed ID: 32525101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography.
    Rout G; Nayak B; Patel AH; Gunjan D; Singh V; Kedia S; Shalimar
    J Clin Exp Hepatol; 2019; 9(2):207-214. PubMed ID: 31024203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of transient elastography to assess hepatic steatosis and fibrosis in patients with juvenile idiopathic arthritis during methotrexate treatment.
    Niyasom C; Soponkanaporn S; Vilaiyuk S; Lertudomphonwanit C; Getsuwan S; Tanpawpong P; Kaewduang P; Sobhonslidsuk A
    Clin Rheumatol; 2024 Jan; 43(1):423-433. PubMed ID: 38062311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis.
    Chalasani S; Mathur K; Shammas N; Orman E; Vuppalanchi R; Lammert C
    Medicine (Baltimore); 2020 Oct; 99(42):e22805. PubMed ID: 33080756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.
    Hayashi H; Kamada Y; Fujii H; Takahashi H; Oeda S; Iwaki M; Kawaguchi T; Tomita E; Yoneda M; Tokushige A; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T;
    Ultrasound Med Biol; 2023 Jul; 49(7):1658-1664. PubMed ID: 37120329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic.
    Avcu A; Kaya E; Yilmaz Y
    Turk J Gastroenterol; 2021 May; 32(5):466-472. PubMed ID: 34231477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome.
    Mikolasevic I; Milic S; Orlic L; Stimac D; Franjic N; Targher G
    J Diabetes Complications; 2016; 30(7):1347-53. PubMed ID: 27324703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.